To announce the change of the company's
spokesperson
Date of events
2022/03/04
To which item it meets
paragraph 8
Statement
1.Type of personnel changed (please enter: spokesperson, acting
spokesperson, important personnel (CEO, COO, CMO, CSO, etc.)
,financial officer, accounting officer, corporate governance officer,
research and development officer, chief internal auditor, or
designated and non-designated representatives):Spokesperson
2.Date of occurrence of the change:2022/03/04
3.Name, title, and resume of the previous position holder:Jess Tang,
Vice President of Administration Division of ScinoPharm Taiwan, Ltd.
4.Name, title, and resume of the new position holder:None
5.Type of the change (please enter: "resignation", "position
adjustment", "dismissal", "retirement", "death" or "new
replacement"):Resignation
6.Reason for the change:Resignation
7.Effective date:2022/03/05
8.Any other matters that need to be specified:The announcement of the
new spokesperson will be made after the Board's appointment.
Attachments
Original Link
Original Document
Permalink
Disclaimer
ScinoPharm Taiwan Ltd. published this content on 04 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 March 2022 09:25:05 UTC.
ScinoPharm Taiwan Ltd is a Taiwan-based company mainly engaged in the research, development, manufacture and sale of active pharmaceutical ingredients. The main products include active pharmaceutical ingredients, protein drugs, oligonucleotides, peptides, injection preparations, new small molecule drugs and other chemical raw materials. The Company is also engaged in the provision of consulting and biotechnology services for related products, the international trading of products, as well as the provision of customized full-process services such as chemical molecular component synthesis, process development and commercial mass production. The Company operates within the domestic market and to overseas markets, including the Americas, Europe, Australia and Asia.